Werewolf Therapeutics (HOWL) Insider Trading & Ownership $0.87 -0.03 (-3.47%) As of 03:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Werewolf Therapeutics (NASDAQ:HOWL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage21.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$4,607.40 Get HOWL Insider Trade Alerts Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HOWL Insider Buying and Selling by Quarter Werewolf Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2025Bioventures 2014 L.P. MpmMajor ShareholderSell1,963$1.05$2,061.15 3/27/2025Luke EvninDirectorSell2,425$1.05$2,546.25 (Data available from 1/1/2013 forward) HOWL Insider Trading Activity - Frequently Asked Questions Who is on Werewolf Therapeutics's Insider Roster? The list of insiders at Werewolf Therapeutics includes Bioventures 2014 L.P. Mpm, Luke Evnin, and Ra Capital Management, L.P.. Learn more on insiders at HOWL. What percentage of Werewolf Therapeutics stock is owned by insiders? 21.10% of Werewolf Therapeutics stock is owned by insiders. Learn more on HOWL's insider holdings. Which Werewolf Therapeutics insiders have been selling company stock? The following insiders have sold HOWL shares in the last 24 months: Bioventures 2014 L.P. Mpm ($2,061.15), and Luke Evnin ($2,546.25). How much insider selling is happening at Werewolf Therapeutics? Insiders have sold a total of 4,388 Werewolf Therapeutics shares in the last 24 months for a total of $4,607.40 sold. Werewolf Therapeutics Key ExecutivesDr. Daniel J. Hicklin Ph.D. (Age 60)Founder, CEO, President, Secretary & Director Compensation: $928.26kMr. Timothy W. Trost CPA (Age 66)CFO, Treasurer & Assistant Secretary Compensation: $662.99kDr. Randi Isaacs M.D. (Age 68)Chief Medical Officer Compensation: $702.43kDr. Chulani Karunatilake Ph.D. (Age 64)Chief Technology Officer Compensation: $343.43kMs. Ellen A. Lubman M.B.A. (Age 48)Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies Journey Medical Insider Selling Fate Therapeutics Insider Selling 4D Molecular Therapeutics Insider Selling Puma Biotechnology Insider Selling Protara Therapeutics Insider Selling Inhibikase Therapeutics Insider Selling Nkarta Insider Selling Coherus BioSciences Insider Selling Lyell Immunopharma Insider Selling scPharmaceuticals Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:HOWL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HOWL Stock Free HOWL Stock Alerts